BR9909791A - Tratamento de distúrbios de ansiedade de modo geral com a partoxetina - Google Patents

Tratamento de distúrbios de ansiedade de modo geral com a partoxetina

Info

Publication number
BR9909791A
BR9909791A BR9909791-5A BR9909791A BR9909791A BR 9909791 A BR9909791 A BR 9909791A BR 9909791 A BR9909791 A BR 9909791A BR 9909791 A BR9909791 A BR 9909791A
Authority
BR
Brazil
Prior art keywords
treatment
general
partoxetine
anxiety disorders
human
Prior art date
Application number
BR9909791-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Rocco Zaninelli
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR9909791A publication Critical patent/BR9909791A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9909791-5A 1998-04-22 1999-04-22 Tratamento de distúrbios de ansiedade de modo geral com a partoxetina BR9909791A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment
PCT/US1999/008786 WO1999053919A1 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Publications (1)

Publication Number Publication Date
BR9909791A true BR9909791A (pt) 2000-12-26

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909791-5A BR9909791A (pt) 1998-04-22 1999-04-22 Tratamento de distúrbios de ansiedade de modo geral com a partoxetina

Country Status (20)

Country Link
EP (1) EP1073437A4 (cs)
JP (1) JP2002512189A (cs)
KR (1) KR20010034817A (cs)
CN (1) CN1298301A (cs)
AP (1) AP2000001959A0 (cs)
AU (1) AU3864899A (cs)
BG (1) BG104939A (cs)
BR (1) BR9909791A (cs)
CA (1) CA2328896A1 (cs)
CZ (1) CZ20003885A3 (cs)
EA (1) EA200001088A1 (cs)
GB (1) GB9808479D0 (cs)
HU (1) HUP0101350A3 (cs)
ID (1) ID27546A (cs)
IL (1) IL139167A0 (cs)
NO (1) NO20005286L (cs)
PL (1) PL343494A1 (cs)
SK (1) SK15672000A3 (cs)
TR (1) TR200003082T2 (cs)
WO (1) WO1999053919A1 (cs)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
IL139167A0 (en) 2001-11-25
EA200001088A1 (ru) 2001-04-23
WO1999053919A1 (en) 1999-10-28
CA2328896A1 (en) 1999-10-28
BG104939A (bg) 2001-09-28
AP2000001959A0 (en) 2000-12-31
ID27546A (id) 2001-04-12
KR20010034817A (ko) 2001-04-25
CZ20003885A3 (cs) 2001-09-12
CN1298301A (zh) 2001-06-06
NO20005286D0 (no) 2000-10-20
PL343494A1 (en) 2001-08-27
EP1073437A4 (en) 2003-04-16
EP1073437A1 (en) 2001-02-07
TR200003082T2 (tr) 2001-01-22
HUP0101350A2 (hu) 2002-05-29
JP2002512189A (ja) 2002-04-23
SK15672000A3 (sk) 2001-04-09
GB9808479D0 (en) 1998-06-17
HUP0101350A3 (en) 2002-06-28
AU3864899A (en) 1999-11-08
NO20005286L (no) 2000-12-20

Similar Documents

Publication Publication Date Title
BR9602485A (pt) Método para o tratamento da doença de Parkinson composição farmacêutica primeira composição farmacêutica e método para a obtenção de efeito antiParkinson
PT840601E (pt) Thip para o tratamento de desordens do sono
BE2012C005I2 (cs)
BR0009776A (pt) Método de tratamento
DK0998287T3 (da) Anvendelse af levobupivacain
MXPA04001187A (es) Receptores de interleucina-1 en el tratamiento de enfermedades.
EA200200194A1 (ru) Антагонисты хемокинного рецептора и способы их применения
ATE496048T1 (de) Phenylcarboxamidverbindungen zur schmerzbehandlung
BR9914631A (pt) Composição imunológica oral indutora de tolerância para prevenção e/ou tratamento de enfermidades e método para prevenção e/ou tratamento de enfermidades
AU8091787A (en) The use of paroxetine to treat pain
MXPA05011432A (es) Uso de dipiridamol o mopidamol para tratamiento y prevencion de enfermedades trombo-embolicas y desordenes originados por formacion excesiva de trombina y/o por expresion elevada de receptores de trombina.
EP0699439A3 (en) Treatment of diseases caused by sebum with inhibitors of acyl CoA cholesterol acyltransferase
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
DK0636027T3 (da) Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
WO2005056601A3 (en) Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse?
WO2002020619A3 (en) HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
BR9814867A (pt) Método para tratar discinesias relacionadas a doenças ou induzidas por drogas
BR9909791A (pt) Tratamento de distúrbios de ansiedade de modo geral com a partoxetina
BR9916391A (pt) Compostos de triazineona para o tratamento de doenças causadas por sarcosiste, neopora e toxoplasma
BR0113646A (pt) Tratamento de distúrbios inflamatórios
BR9811004A (pt) "tratamento e prevenção de distúrbios cardìacos usando inibidores seletivos (ssri) da reelevação do nìvel de serotonina"
BR9809376A (pt) Pregnan-3-ol-20-onas
BR9911150A (pt) Método de tratamento

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1917 DE 02/10/2007.